ArticleJournal of cardiac failure2023
Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America.
4 registry-linked trialsAbstract read
In one paragraph
Article in Journal of cardiac failure, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 340 papers, 10 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
340citing papers in PubMed, 10 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
MRI of Epicardial Adipose Tissue Composition: Development of Methods and Application to Heart Failure With Preserved Ejection Fraction
PMID 37814776PMID 37325396PMID 37021018PMID 36870978PMID 35726367PMID 35714617PMID 35296869PMID 34890762PMID 33720759PMID 32844500PMID 31782934PMID 31202119other papers from this trial
Open the trial in the graphNCT07018297 phase3not yet recruitingnot on this mapstarted 2026, after this paper: background citation
Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure: A Cluster-Randomized Crossover Non-Inferiority Trial
A Prospective, Cross-sectional, Nationwide Community-based Observational Study to Determine the Prevalence of Unrecognized Heart Failure Among Patients at Risk in Urban Areas Across Germany Using CMR
Implementing Community Palliative Care for People With Heart Failure
Who cites it
340 citing papers in PubMed, 10 syntheses or guidelines pooled it.
- Cost-Effectiveness of Sodium-Glucose Co-Transporter-2 Inhibitors and Angiotensin Receptor-Neprilysin Inhibitors by Ejection Fraction and Drug Pricing in the United States: A Systematic Review.Circulation. Population health and outcomes · 2026Pooled it
- Effectiveness of transitional care program in older adults with heart failure: a systematic review and meta-analysis of randomised controlled trials.BMC geriatrics · 2026Pooled it
- Biomarker-Guided Versus Clinically Guided Management Strategies for Heart Failure: A Systematic Review and Meta-Analysis.Reviews in cardiovascular medicine · 2026Pooled it
- Effect of Finerenone in Cardiovascular and Renal Outcomes: A Systematic Review and Meta-analysis.Cardiovascular drugs and therapy · 2026Pooled it
- Sodium-glucose Cotransporter 2 Inhibitors Association with Risk of Heart Failure Hospitalization in Preserved and Mildly Reduced Ejection Fraction, Regardless of Diabetes Mellitus: A Systematic Review and Meta-Analysis.Current cardiology reviews · 2026Pooled it
- Comparative efficacy of continuous versus intermittent administration of furosemide in acute heart failure: an updated systematic review and meta-analysis of 22 RCTs.Frontiers in cardiovascular medicine · 2026Pooled it
- SGLT2 Inhibitors in Older Adults With Cardiovascular Disease: A Systematic Review and Meta-Analysis.Journal of the American Geriatrics Society · 2025Pooled it
- Quality of Life in Chronic Heart Failure With Obstructive Sleep Apnea: A Systematic Review.Nursing open · 2025Pooled it
- Pharmacokinetic Alterations in Patients with Chronic Heart Failure: A Systematic Review.International journal of molecular sciences · 2025Pooled it
- Renal Biomarkers and Prognosis in HFpEF and HFrEF: The Role of Albuminuria and eGFR-A Systematic Review.Medicina (Kaunas, Lithuania) · 2025Pooled it
- Patient Perceptions of a Digitally Enabled Community Health Worker Intervention: Qualitative Study Among Pilot Trial Participants.JMIR cardio · 2026Trial
- The ALT FLOW early feasibility study 3-year results assessing left atrial to coronary sinus shunting in HFpEF.ESC heart failure · 2026Trial
- Rationale and Design of the Cooperative Program for ImpLementation of Optimal Therapy in Heart Failure.Clinical cardiology · 2026Trial
- Sacubitril/valsartan versus valsartan initiation in patients naïve to renin-angiotensin system inhibitors: Insights from PARAGLIDE-HF.European journal of heart failure · 2025Trial
- Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial.European journal of heart failure · 2025Trial
- Equal Treatment, Unequal Outcomes? Debunking the Racial Disparity in Renin Angiotensin Aldosterone System Inhibitor-Associated Reduction in Heart Failure Hospitalizations.Journal of cardiac failure · 2025Trial
- In-Hospital or Out-of-Hospital Initiation of Sacubitril/Valsartan Versus Valsartan in Patients With Mildly Reduced or Preserved Ejection Fraction After A Worsening Heart Failure Event: The PARAGLIDE-HF Trial.Journal of the American Heart Association · 2025Trial
- Native QRS duration and outcomes in heart failure with mildly reduced ejection fraction: results from a large-scaled registry.Clinical research in cardiology : official journal of the German Cardiac Society · 2026Article
- NT-proBNP in the very old population: reference values and heart failure specificity from the AugUR-study.Clinical research in cardiology : official journal of the German Cardiac Society · 2026Article
- Contemporary medical therapy for heart failure with mildly reduced or preserved ejection fraction.Heart failure reviews · 2026Review
280 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors.
Biykem BozkurtWinters Center for Heart Failure, Cardiology, Baylor College of Medicine, Houston, Texas. Electronic address: bbozkurt@bcm.edu.
Tariq AhmadHeart Failure Program Yale School of Medicine, Yale School of Medicine, New Haven, Connecticut.
Kevin M AlexanderCardiovascular Medicine, Stanford University, Stanford University School of Medicine, Stanford, California.
William L BakerUCONN School of Pharmacy, Storrs, Connecticut.
Kelly BosakKU Medical Center, School Of Nursing, Kansas City, Kansas.
Khadijah BreathettDivision of Cardiology, Indiana University School of Medicine, Indianapolis, Indiana.
Gregg C FonarowDivision of Cardiology, University of California Los Angeles, Los Angeles, California.
Paul HeidenreichCardiovascular Medicine, Stanford University, Stanford University School of Medicine, Stanford, California.
Jennifer E HoAdvanced Heart Failure and Transplant Cardiology, Beth Israel Deaconess, Boston, Massachusetts.
Eileen HsichCardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.
Nasrien E IbrahimAdvanced Heart Failure and Transplant, Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA.
Lenette M JonesDepartment of Health Behavior and Biological Sciences, University of Michigan, School of Nursing, Ann Arbor, Michigan.
Sadiya S KhanNorthwestern University, Cardiology Feinberg School of Medicine, Chicago, Illinois.
Prateeti KhazanieAdvanced Heart Failure and Transplant Cardiology, UC Health, Aurora, Colorado.
Todd KoellingFrankel Cardiovascular Center. University of Michigan, Ann Arbor, Michigan.
Harlan M KrumholzHeart Failure Program Yale School of Medicine, Yale School of Medicine, New Haven, Connecticut.
Kiran K KhushCardiovascular Medicine, Stanford University, Stanford University School of Medicine, Stanford, California.
Christopher LeeBoston College William F. Connell School of Nursing, Boston, Massachusetts.
Alanna A MorrisDivision of Cardiology, Emory School of Medicine, Atlanta, Georgia.
Robert L PageDepartments of Clinical Pharmacy and Physical Medicine, University of Colorado, Aurora, Colorado.
Ambarish PandeyCardiology, Department of Medicine, UT Southwestern Medical Center, Dallas, Texas.
Mariann R PianoVanderbilt School of Nursing, Nashville, Tennessee.
Josef StehlikAdvanced Heart Failure Section, Cardiology, University of Utah School of Medicine, Salt Lake City, Utah.
Lynne Warner StevensonCardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
John R TeerlinkCardiology University of California San Francisco (UCSF), San Francisco, California.
Muthiah VaduganathanCardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Boback ZiaeianDivision of Cardiology, University of California Los Angeles, Los Angeles, California.
Writing Committee Members
Funding
Yale Clinical and Translational Science AwardUL1TR001863 · YALE UNIVERSITY · 2025 to 2025
$9.9MUCLA-UCI Center for Eliminating Cardio-Metabolic Disparities in Multi-Ethnic Populations (UC END-DISPARITIES)P50MD017366 · UNIVERSITY OF CALIFORNIA LOS ANGELES · 2025 to 2025
$3.3MReal time risk prognostication via scalable hazard trees and forestsR01HL164405 · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · 2025 to 2025
$591kNCATS NIH HHS UL1 TR001863NHLBI NIH HHS R01 HL141892NHLBI NIH HHS R01 HL164405NIMHD NIH HHS P50 MD017366
Abstract
PubMed holds no abstract for this paper.
Indexed as
Heart FailureHospitalizationHumansIncidencePrevalenceepidemiologyHeart failureincidencemortalityoutcomesprevalence
Identifiers
What Socratic holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
NCT07178145ClinicalTrials.gov
NCT07018297ClinicalTrials.gov
NCT07185100ClinicalTrials.gov
NCT07356843ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.